Related Experiment Video
Updated: Apr 28, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma
Zhenpeng Gu1, Guofeng Ding2, Kuixiang Liang1
1Department of Obstetrics and Gynecology, Affiliated Hospital of Binzhou Medical College, Binzhou, China (mainland).
Background:
The TESTIN gene was demonstrated to be a tumor suppressor in prostate and breast cancer through inhibiting tumor growth and invasion. Herein, we aimed to investigate the detailed functions of TESTIN in the highly sexual hormone (estrogen)-dependent malignancy, endometrial carcinoma.
Material And Methods:
TESTIN mRNA and protein expression were measured by qRT-PCR, Western blot and immunohistochemistry. Upregulation of TESTIN was achieved by transfecting the pcDNA3.1-TESTIN plasmids into AN3CA cells. Knockdown of TESTIN was achieved by transfecting the shRNA-TESTIN into Ishikawa cells. MTT assay, colony formation assay, and Transwell assay were used to investigate the effects of TESTIN on cellular proliferation and invasion. The apoptotic status and cell cycle were analyzed using flow cytometry. MMP2 secretion was determined by ELISA assay. The xenograft assay was used to investigate the functions of TESTIN in nude mice.
Results:
Compared to the non-malignant adjacent endometrium, 54% of tumor samples presented downregulation of TESTIN (P<0.001). Loss of TESTIN protein was correlated with advanced tumor stage (P=0.047), high grade (P=0.034), and lymphatic vascular space invasion (P=0.036). In vitro, overexpression of TESTIN suppressed cell proliferation, induced dramatic G1 arrest, and inhibited tumor invasion through blocking the secretion of MMP2. Loss of TESTIN accelerated cellular proliferation, promoted cell cycle progression, and enhanced tumor invasion by increasing the secretion of MMP2. Consistently, TESTIN could significantly delay the growth of xenografts in nude mice.
Conclusions:
TESTIN was commonly downregulated in human endometrial carcinoma and was associated with poor prognostic markers. Moreover, TESTIN significantly inhibited tumor growth and invasion via arresting cell cycle in in vitro and in vivo experiments. Therefore, we propose that TESTIN might be a prognostic marker and therapeutic target for endometrial carcinoma.
Insights
TESTIN acts as a tumor suppressor in endometrial carcinoma, often downregulated in tumors. Restoring TESTIN inhibits cancer growth and invasion, suggesting its potential as a prognostic marker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- TESTIN gene functions as a tumor suppressor in prostate and breast cancers.
- Investigated TESTIN's role in estrogen-dependent endometrial carcinoma.
Purpose of the Study:
- To elucidate the detailed functions of TESTIN in endometrial carcinoma.
- To assess TESTIN's potential as a prognostic marker and therapeutic target.
Main Methods:
- Gene expression analysis (qRT-PCR, Western blot, IHC).
- In vitro studies: cell transfection (overexpression/knockdown), proliferation assays (MTT, colony formation), invasion assays (Transwell), cell cycle and apoptosis analysis (flow cytometry), MMP2 secretion assay (ELISA).
- In vivo studies: xenograft assay in nude mice.
Main Results:
- TESTIN was downregulated in 54% of endometrial tumors, correlating with advanced stage, high grade, and lymphovascular invasion.
- TESTIN overexpression suppressed proliferation, induced G1 arrest, and inhibited invasion by blocking MMP2 secretion.
- TESTIN knockdown accelerated proliferation, promoted cell cycle, and enhanced invasion via increased MMP2 secretion.
- TESTIN overexpression significantly delayed xenograft tumor growth in vivo.
Conclusions:
- TESTIN is frequently downregulated in endometrial carcinoma and associated with poor prognostic markers.
- TESTIN inhibits tumor growth and invasion by arresting the cell cycle.
- TESTIN is a potential prognostic marker and therapeutic target for endometrial carcinoma.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Mitogens and the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Replicative Cell Senescence
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

